James J. Koziarz

Rubicon Genomics, Inc. engages in the provision of pre-analytical amplification technologies. The firm specializes in enzymology, nucleic acid chemistry, sample processing and manufacturing. The company was founded by Dr. John Langmore and Vladimir Makarov in 2000 and is headquartered in Ann Arbor, MI.

InformMed, Inc. provided medication safety solutions. The company was founded by Katharine Francis in 2001 and was headquartered in Peoria, IL.

Verax Biomedical, Inc. develops rapid tests for detecting bacterial contaminants in blood cells and tissues. The firm's first target application for its technology is to test for the presence of bacterial contaminants in platelets and bacterial contaminants in platelets and red blood cells represent the greatest lethal infectious risks in transfusion medicine today and no rapid, simple methods are presently available to effectively address this threat. Verax Biomedical was founded by Joe R. Sanders and Joe L. Straight in 1999 and is headquartered in Marlborough, MA.

NephRx Corp. provides therapeutic products for the treatment of kidney failures. The firm's flagship product includes NX001 is a kidney growth factor peptide for acute renal failure that is currently in preclinical development for treatment of delayed graft function in transplant patients. The company was founded in 2001 by Pratik Shah and is headquartered in Kalamazoo, Michigan.

HYCOR Biomedical, Inc. manufactures in vitro diagnostic products for allergy and autoimmune testing. The firm’s products include allergy testing, autoimmune testing, HYTEC 288 plus and HCOR ultra-sensitive EIA. It markets the HYTEC, KOVA and AUTOSTAT brands. The company was founded in 1981 and is headquartered in Garden Grove, CA.

Abbott Diagnostics, Inc. develops, manufactures and sells medical diagnostic instrument, test and automation products. The company is headquartered in Santa Clara, CA.

Inspirotec, Inc. is a company based in North Chicago, IL that provides airborne biological matter detection through indoor air quality companies and experts. The company's highly sensitive patented technology collects and measures biological agents in the air, including viruses such as SARS-CoV-2, allergens, molds, and bacteria down to 0.1 microns. The company's mission is to deliver customized prevention and management solutions to improve health and peace of mind by transforming indoor environments everywhere. The technology has been developed in collaboration with institutions including Johns Hopkins University, the University of Chicago, Harvard University, and Argonne National Laboratory, and has been validated with an extensive portfolio of patents and publications in peer-reviewed literature. The company was founded in 2011 by Julian Gordon, and the CEO is James J. Koziarz.